It was great to to meet some new faces You might have heard about our office in LA (or not, which is okay too, but not really, so read about it). On June 5th, we hosted our first Dribbble meetup, a gathering of sorts with other designers. Dribbble is a community designers use to showcase...

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day. Cannabidiol, one of dozens of active cannabinoids found in the marijuana plant, can reduce the frequency of seizures in patients suffering from two rare forms of epilepsy called Dravet and Lennox-Gastaut syndromes, according to...

In May, the government of Zimbabwe announced a law that allows farmers to grow and sell cannabis for medical and research purposes. The country becomes only the second in Africa to permit medical marijuana, Lesotho being the first to do so in 2017. The new policy would give researchers in Zimbabwe the ability to conduct...

Canada Could Come to the Fore in Cannabis Research

On October 20, marijuana will no longer be an illegal drug in Canada—a move that could make it much easier to study how cannabis affects the body and the brain. Currently in Canada, to study the physiological effects of cannabis in humans, researchers have to apply for an exemption from the Controlled Drugs and Substances...

The US Food and Drug Administration today approved for the first time a marijuana-derived drug, Epidiolex, for the treatment of two rare forms of epilepsy. The drug contains cannabidiol, or CBD, and does not make users high while reducing the rate of seizures in patients with Dravet or Lennox-Gastaut syndromes, clinical trials show. “In my...

All rights reserved 2019.